Index of artpub/2024/302147/

Kiladjian, Jean-Jacques
ROP-ET : a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
2024
https://ddd.uab.cat/record/302147